Merck Group total revenues rose 16% in the second quarter to a record EUR 2,208 million from EUR 1,910 million in the year-ago quarter with the Chemicals divisions showing outstanding growth and the Pharmaceuticals divisions also posting significant increases.
Revenues were also boosted by a 4.7% positive currency effect. For the first half, Group revenues were up 14% to EUR 4,307 million.
Royalty and commission income increased 26% to EUR 105 million in the second quarter, mainly stemming from the Merck Serono division. Half-year royalty and commission income declined 1.9% to EUR 181 million.
|
Components of growth by division – Q2 |
XLS | |||||
|
|
|
|
|
|
|
|
|
Change in total revenues |
Merck Serono |
Consumer Health Care |
Liquid Crystals |
Performance & Life Science Chemicals |
Merck |
Merck Group |
|
Organic growth |
6.4 |
12.0 |
37.3 |
12.4 |
– |
10.7 |
|
Currency effects |
3.6 |
–2.6 |
12.8 |
7.4 |
– |
4.7 |
|
Acquisitions /divestments |
– |
– |
– |
1.2 |
– |
0.2 |
|
Total |
10.0 |
9.4 |
50.1 |
20.9 |
– |
15.6 |